A total of 309 patients with BSI fulfilled the study criteria: 69 patients without consecutive ICDSC scores on all three defined days or with delirium prior to the diagnosis of BSI were excluded.
A Veteran's person-time was measured from date of PTSD diagnosis (or the index date for comparison group members) to the first non-fatal ISH episode resulting in hospitalization, death, or end of the last fiscal year in which a patient fulfilled the study definition of a VA health care user, whichever came first.
Those who fulfilled the study entry criteria were given a maximum of three doses of salbutamol (400 microgm/dose) by either a nebuliser or metered dose inhaler and their respiratory rate was reassessed.
Forty-one patients were included and fulfilled the study.
These 400 patients fulfilled the study criteria and were enrolled for antiviral therapy.
50 of them fulfilled the study criteria and agreed to participate in the study.
From May 2005 until July 2008, 1,199 patients fulfilled the study inclusion criteria.
Of those, 170 patients fulfilled the study criteria and 134 (79%) had sufficient data for analysis.
One hundred and thirty-two subjects fulfilled the study criteria and entered this study.
However, there were only 88 parents who fulfilled the study criteria.
A total of 211 patients fulfilled the study criteria, of whom 803838%) were female.
